The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world data (RWD) reveals benefit for adjuvant chemotherapy with docetaxel, oxaliplatin and fluorouracil/leucovorin (FLOT) is limited to those with tumour regression grade (TRG) ≥3 in oesophago-gastric cancer (OGC).
 
Brindley Sonal Hapuarachi
No Relationships to Disclose
 
Rebecca Lee
Speakers' Bureau - AstraZeneca
Research Funding - Bristol-Myers Squibb (Inst)
 
Adeel Khan
No Relationships to Disclose
 
Laura Woodhouse
No Relationships to Disclose
 
Valentinos Kounnis
No Relationships to Disclose
 
Fiona Britton
No Relationships to Disclose
 
Jessica Coyle
No Relationships to Disclose
 
Kathleen Connors
No Relationships to Disclose
 
Neethu Billy Graham Mariam
No Relationships to Disclose
 
Jamie Weaver
No Relationships to Disclose
 
Tom Waddell
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; Merck Sharp & Dohme; Pfizer; Roche
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EUSA Pharma; Ipsen
 
Richard Hubner
Honoraria - Abbott Nutrition; Ipsen
Consulting or Advisory Role - BTG; Eisai; Shire
Travel, Accommodations, Expenses - Bayer; BMS; Roche
 
Konstantinos Kamposioras
No Relationships to Disclose
 
Wasat Mansoor
Consulting or Advisory Role - Bristol-Myers Squibb; SERVIER
Speakers' Bureau - SERVIER
Travel, Accommodations, Expenses - Bristol-Myers Squibb